Evolving landscape of payer coverage for cell and gene therapies (CGTs): Trends and insights

This resource examines key payer trends, including early engagement strategies, utilization management tools, and reimbursement challenges. Based on primary research conducted in July and August 2025 with 19 formulary decision-makers from our Managed Care Network (MCN) panel—representing over 180 million covered lives—it provides expert insights on market access, formulary evaluations, innovative payment models, and the future of CGTs. With actionable data and insights, this report is your guide to staying ahead in the transformative world of CGTs.